Format

Send to

Choose Destination
J Urol. 2016 Apr;195(4 Pt 1):1172-3. doi: 10.1016/j.juro.2015.11.040. Epub 2016 Jan 16.

Re: Editorial Comment on Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma: D. F. Penson J Urol 2015;194:1710-1711.

Author information

1
Department of Urology and Population Health, New York University and Manhattan Veterans Affairs Medical Center, New York, New York. Electronic address: stacyloeb@gmail.com.
2
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
3
Department of Surgery and Perioperative Sciences, Urology and Andrology, Umeå University Hospital, Umeå; Department of Urology, Uppsala University Hospital, Uppsala, Sweden.
PMID:
26783933
DOI:
10.1016/j.juro.2015.11.040
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center